Sanofi (LON: 0A2V)

Sanofi Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	41,081	43,070	42,997	37,761	36,041
Other Revenue	3,205	2,963	2,392	1,414	1,328
Revenue	44,286	46,033	45,389	39,175	37,369
Revenue Growth (YoY)	-3.80%	1.42%	15.86%	4.83%	-0.70%
Cost of Revenue	13,205	14,216	13,692	12,251	12,106
Gross Profit	31,081	31,817	31,697	26,924	25,263
Selling, General & Admin	9,183	10,765	10,539	9,599	9,448
Research & Development	7,394	6,728	6,706	5,692	5,530
Other Operating Expenses	3,687	2,950	1,587	1,488	1,025
Operating Expenses	22,013	22,615	20,659	18,359	17,684
Operating Income	9,068	9,202	11,038	8,565	7,579
Interest Expense	-1,073	-527	-394	-362	-459
Interest & Investment Income	519	546	173	3	37
Earnings From Equity Investments	60	-115	68	39	359
Currency Exchange Gain (Loss)	-	-2	-4	2	-6
Other Non Operating Income (Expenses)	-	-665	37	70	144
EBT Excluding Unusual Items	8,574	8,439	10,918	8,317	7,654
Merger & Restructuring Charges	-1,396	-1,510	-1,339	-824	-1,142
Gain (Loss) on Sale of Investments	-	-1	1	3	7,388
Gain (Loss) on Sale of Assets	394	688	655	418	443
Asset Writedown	-9	-896	228	-192	-330
Legal Settlements	-470	-	-	-	-
Other Unusual Items	-96	318	27	115	124
Pretax Income	6,997	7,038	10,490	7,837	14,137
Income Tax Expense	1,259	1,602	2,006	1,558	1,807
Earnings From Continuing Operations	5,738	5,436	8,484	6,279	12,330
Earnings From Discontinued Operations	64	-	-	-	-
Net Income to Company	5,802	5,436	8,484	6,279	12,330
Minority Interest in Earnings	-58	-36	-113	-56	-36
Net Income	5,744	5,400	8,371	6,223	12,294
Net Income to Common	5,744	5,400	8,371	6,223	12,294
Net Income Growth	6.37%	-35.49%	34.52%	-49.38%	346.41%
Shares Outstanding (Basic)	1,251	1,252	1,252	1,253	1,254
Shares Outstanding (Diluted)	1,251	1,256	1,257	1,258	1,260
Shares Change (YoY)	-0.40%	-0.04%	-0.08%	-0.17%	0.24%
EPS (Basic)	4.59	4.31	6.69	4.97	9.81
EPS (Diluted)	4.59	4.30	6.66	4.95	9.76
EPS Growth	6.75%	-35.44%	34.55%	-49.28%	345.73%
Free Cash Flow	-	8,539	8,920	9,044	6,164
Free Cash Flow Per Share	-	6.80	7.10	7.19	4.89
Dividend Per Share	3.920	3.760	3.560	3.330	3.200
Dividend Growth	4.26%	5.62%	6.91%	4.06%	1.59%
Gross Margin	70.18%	69.12%	69.83%	68.73%	67.60%
Operating Margin	20.48%	19.99%	24.32%	21.86%	20.28%
Profit Margin	12.97%	11.73%	18.44%	15.89%	32.90%
Free Cash Flow Margin	-	18.55%	19.65%	23.09%	16.49%
EBITDA	12,386	12,520	14,062	11,251	10,466
EBITDA Margin	27.97%	27.20%	30.98%	28.72%	28.01%
D&A For EBITDA	3,318	3,318	3,024	2,686	2,887
EBIT	9,068	9,202	11,038	8,565	7,579
EBIT Margin	20.48%	19.99%	24.32%	21.86%	20.28%
Effective Tax Rate	17.99%	22.76%	19.12%	19.88%	12.78%

Source: S&P Capital IQ. Standard template. Financial Sources.